ABBV vs QCOM: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and QUALCOMM Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-16.
AbbVie Inc. · Healthcare
$208.05
+4.5% upside to fair value
Grade C
High Quality
VS
QUALCOMM Incorporated · Technology
$134.47
+77.7% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
QCOM has more upside to fair value
(+77.7%).
ABBV trades at a lower forward P/E
(14.9x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
QCOM |
| Current Price |
$208.05 |
$134.47 |
| Fair Value Estimate |
$217.50 |
$239.00 |
| Upside to Fair Value |
+4.5%
|
+77.7%
|
| Market Cap |
$367.9B |
$143.6B |
| Forward P/E |
14.9x
|
26.8x
|
| EV / EBITDA |
16.7x
|
—
|
| Price / Sales |
6.1x
|
3.2x
|
| Price / FCF |
20.9x
|
11.1x
|
| Revenue Growth YoY |
+8.6%
|
+8.7%
|
| Gross Margin |
83.7%
|
55.1%
|
| Operating Margin |
34.7%
|
27.1%
|
| Return on Equity |
-129.24%
|
21.6%
|
| Dividend Yield |
3.2% |
— |
| FCF Yield |
4.78%
|
9.0%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
AbbVie is a leading diversified biopharmaceutical company navigating the post-Humira transition with strong momentum from Skyrizi and Rinvoq in immunology and continued growth in neuroscience. Full-year 2025 revenue reached $61.2 billion with a gross margin of 83.7% and operating margin of 34.7%, demonstrating operational strength despite the ongoing Humira erosion. Management guides to $67 billi…
Qualcomm Incorporated is a leading semiconductor company specializing in wireless chipsets and IP licensing, with dominant positions in 5G modems via QCT (87% of revenue) and steady QTL royalties. The business excels through a vast patent moat, diversification into automotive and IoT, and robust growth (revenue +13% YoY to $44B in FY2025), but faces risks from Apple modem shifts and China exposur…
Accumulation Zones
| Metric |
ABBV |
QCOM |
| Zone Low |
$163.13 |
$179.00 |
| Zone High |
$184.88 |
$203.00 |
| In Buy Zone? |
No
|
Yes
|